Definition: In this task, you are given a text of many news articles seperated by special token "|||||". Your task is to summarize them.
Input: Public Health 
  
 In Canada, Gonorrhea Defeats Another Antibiotic 
  
 Gonorrhea is one tough germ to beat. 
  
 Over the past 70 years, the bug has outwitted four classes of antibiotics, leaving just one set of drugs available to kill it. 
  
 Now there's more evidence that the arsenal against gonorrhea is shrinking again. 
  
 Canadian doctors have documented the first failure in North America of cefixime, the front-line antibiotic for gonorrhea. 
  
 Although the study was small – the doctors looked at only 133 cases total — nearly 7 percent of patients failed to be cured by the standard dose of cefixime, sold under the brand-name Suprax. 
  
 The findings are published in the current issue of JAMA, the Journal of the American Medical Association. 
  
 "We've heard of such cases in Asia and Europe. Now it's happening in North America," Dr. Robert Kirkcaldy of the U.S. Centers for Disease Control and Prevention tells Shots. "It's very concerning." 
  
 Gonorrhea is the second-most common sexually transmitted disease in the U.S., with more than 300,000 cases reported in 2011. 
  
 "People are often surprised that gonorrhea is still around," Kirkcaldy says. "It's an ancient disease, but it's surprisingly common in some parts of the U.S." 
  
 So far, there have been no treatment failures in the U.S., Kirkcaldy says. "Our treatment option in the U.S. is still highly effective." 
  
 And, even in the Canadian study, all patients eventually recovered when they were given larger doses of cefixime or a related antibiotic. 
  
 Nevertheless, there have been worrying signs of antibiotic-resistant gonorrhea in the U.S. 
  
 For decades, CDC scientists have been keeping a close eye on gonorrhea strains around the country. They've taken samples of the bugs from patients and tested how much cefixime is needed to kill them in the lab. 
  
 The effective dose of cefixime has crept up slowly over the past ten years. The CDC got concerned enough about the trend in August that officials told doctors to stop using cefixime altogether and switch to a related drug called ceftriaxone, or Rochephin. The CDC is looking to preserve cefixime's effectiveness. 
  
 Some doctors, like Dr. Vanessa Allen of Public Health Ontario, worry that gonorrhea will quickly acquire resistance to this other antibiotic, as well, especially since it works by a similar mechanism as cefixime. 
  
 "We need to rethink our strategy of antibiotic use," Allen, who led the JAMA study tells Shots. "We don't have luxury of just switching to another antibiotic," she says because there really aren't any more left for gonorrhea. ||||| At least nine Canadian patients have contracted a strain of "incurable" gonorrhea, according to a study released on Jan. 7 in the Journal of the American Medical Association. 
  
 Researchers found that nine of the 133 patients with gonorrhea who were treated at a Toronto clinic still had the disease after being treated with the oral antibiotic cephalosporins. This marks the first time that cephalosporin-resistant gonorrhea has been found on the continent. 
  
 "We've heard of such cases in Asia and Europe. Now it's happening in North America," Dr. Robert Kirkcaldy, medical epidemiologist in the Division of STD Prevention at CDC's National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, said to NPR. "It's very concerning." 
  
 Gonorrhea is a sexually transmitted infection caused by the Neisseria gonorrhoeae bacteria. It can be spread through contact with the mouth, vagina, penis or anus and thrives in warm, moist areas of the body. 
  
 Symptoms in men include burning and pain while urinating, increased urinary frequency or urgency, penis discharge, red or swollen opening of the penis, tender or swollen testicles and/or a sore throat. Women experience vaginal discharge, burning and pain while urinating, increased urination, sore throat, painful sexual intercourse, pain in the lower abdomen and fever. Arthritis-like symptoms and rashes can occur if the infection has spread in to the blood stream. 
  
 Health care providers in the U.S. are required by law to tell the State Board of Health about anyone they have found that has contracted the bacteria so the patients can get the proper follow-up care and alert their sexual partners. However, out of the more than 700,000 people in the United States who get new gonorrhea infections each year, less than half of these infections are reported to CDC. 
  
 The cephalosporins-resistant strain has been going around globally. In June 2012, the World Health Organization warned doctors about the potential problem, and urged medical professionals to keep a closer eye on the disease. They felt that in a couple of years gonorrhea could potentially be resistant to all treatment currently available. 
  
 However, all nine patients in the study were eventually cured. Six were treated with an injectable antibiotic called ceftriaxone and the last three had to take twice the usual dose of cephalosporins. This led some scientists to question if the latter really had the cephalosporin-resistant strain, the CBC reported. 
  
 Lead author Dr. Vanessa Allen, a medical microbiologist and infectious diseases consultant with Public Health Ontario, told NPR that the takeaway still remains that people should be cautious about antibiotic overuse. 
  
 "We need to rethink our strategy of antibiotic use," Allen said. "We don't have luxury of just switching to another antibiotic (for gonorrhea)." |||||
Output:
There's a new reason to stock up on condoms. An "incurable" (or at least, antibiotic-resistant) strain of gonorrhea has made its way across the pond to North America, according to a new study in the Journal of the American Medical Association. At least nine Canadian patients have failed to respond to the typical dose of cefixime, one of the last antibiotics able to treat the STD. "We've heard of such cases in Asia and Europe," one CDC doctor tells NPR. "It's very concerning." The WHO started warning of the dangers of drug-resistant gonorrhea back in June, predicting that in a few years gonorrhea might be able to resist any available treatment. That isn't the case yet however; all nine Canadian patients were, eventually, cured, most with an injectable antibiotic, CBS News reports.